Amgen

AMGN · NASDAQ

$438.94+$14.00 (+3.29%)TodayMarket closed · Oct 20, 7:59 PM ET

Prev close $424.94

Latest news

Press releaseOct 20, 4:15 PM ETPRNewswire
AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026
NewsOct 20, 12:51 PM ETVandana Singh
AstraZeneca/Amgen Drug Shows Significant Remission in Eosinophilic Esophagitis Study
Press releaseOct 20, 9:00 AM ETPRNewswire
TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS
NewsOct 14, 11:39 AM ETPiero Cingari
Nasdaq 100 Drops 1% on Hot CPI, SOXX Falls 7th Day: Stock Market Today
NewsOct 5, 3:00 PM ETPiero Cingari
Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average
Press releaseSep 28, 8:00 AM ETPRNewswire
KRAS Inhibitor Market Projected to Reach $7.8 Billion by 2034
NewsSep 25, 1:35 PM ET
10 Health Care Stocks With Whale Alerts In Today’s Session
NewsSep 23, 1:35 PM ET
10 Health Care Stocks Whale Activity In Today’s Session
NewsSep 22, 1:56 PM ETVandana Singh
Amgen Hits Primary Endpoint In Sjögren's Trial, But Approval Filing Awaits Another Trial Data
Press releaseSep 22, 9:00 AM ETPRNewswire
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR DAZODALIBEP IN MODERATE-TO-SEVERE SYSTEMIC SJÖGREN'S DISEASE
NewsSep 18, 12:55 PM ETPiero Cingari
Bitcoin Tops $80,000, S&P 500 Slips as Yields Reclaim 5%: Stock Market Today
Press releaseSep 14, 9:00 AM ETPRNewswire
FDA APPROVES REDUCED MONITORING TIME FOR FIRST TWO DOSES OF IMDELLTRA®
NewsSep 12, 8:49 AM ET
Benzinga Bulls and Bears: GameStop, Marvell, Robinhood
NewsSep 11, 1:35 PM ET
10 Health Care Stocks With Whale Alerts In Today’s Session
Press releaseSep 9, 4:01 PM ETPRNewswire
AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
NewsSep 9, 4:01 AM ETMohd Haider
Pyxis Oncology Stock Soars Over 5% Overnight: Here's What You Need to Know
NewsSep 8, 1:17 PM ETPiero Cingari
QUICK SPARK: Amgen Stock Eyes Worst Day Since October 2000
NewsSep 8, 1:13 PM ETPiero Cingari
S&P 500, Nasdaq Slip as $98 Brent Reignites Inflation Fears: Stock Market Today
NewsSep 8, 12:50 PM ETVandana Singh
What's Going On With Amgen Stock Tuesday?
NewsSep 8, 11:47 AM ETVandana Singh
Astrazeneca Secures FDA Approval for New Breast Cancer Treatment
Press releaseSep 8, 9:00 AM ETPRNewswire
IMDELLTRA® IN COMBINATION WITH IMFINZI® DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
NewsSep 8, 8:01 AM ETAvi Kapoor
Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Press releaseSep 2, 4:01 PM ETPRNewswire
AMGEN TO PRESENT AT THE 2026 WELLS FARGO HEALTHCARE CONFERENCE
Press releaseAug 31, 3:18 AM ETPRNewswire
AMGEN'S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE
NewsAug 27, 8:02 AM ETVandana Singh
AstraZeneca, Amgen Score Phase 3 Win in Debilitating Swallowing Disease
Press releaseAug 27, 2:00 AM ETPRNewswire
TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
NewsAug 18, 1:35 PM ET
10 Health Care Stocks Whale Activity In Today’s Session
NewsAug 14, 1:35 PM ET
9 Health Care Stocks Whale Activity In Today’s Session
NewsAug 12, 10:41 PM ETMohd Haider
Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'
NewsAug 7, 8:05 AM ETAvi Kapoor
Chubb, Toast And A Health Care Stock On CNBC’s ‘Final Trades’
NewsAug 5, 2:14 PM ETPiero Cingari
Gold Jumps 4%, Dow Jones Smashes Record Highs: Stock Market Today
NewsAug 4, 4:02 PM ET
Amgen Q2 Adj. EPS $6.29 Beats $5.62 Estimate, Sales $10.054B Beat $9.421B Estimate
Press releaseAug 4, 4:01 PM ETPRNewswire
AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
NewsAug 3, 3:30 PM ETKaustubh Bagalkote
SpaceX Could Swing $204 Billion After Earnings
NewsJul 24, 6:25 AM ETStjepan Kalinic
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
Press releaseApr 30, 4:01 PM ETPRNewswire
AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Press releaseApr 30, 4:01 PM ETPRNewswire
/C O R R E C T I O N -- Amgen/
NewsApr 27, 12:21 PM ETChris Katje
The Dow Jones Earnings Showdown: 11 Blue‑Chips Step Up This Week
NewsFeb 6, 4:00 PM ET
P/E Ratio Insights for Amgen
Press releaseFeb 3, 4:01 PM ETPRNewswire
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
NewsJan 2, 5:06 PM ETChris Katje
Dogs Of The Dow: 10 High-Yield Stocks With Dividends Up To 6.8% - Including Several Warren Buffett Favorites
Press releaseNov 4, 4:01 PM ETPRNewswire
AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
NewsOct 17, 12:00 PM ET
Price Over Earnings Overview: Amgen
NewsOct 3, 3:00 PM ET
P/E Ratio Insights for Amgen

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026

AstraZeneca/Amgen Drug Shows Significant Remission in Eosinophilic Esophagitis Study

TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS

Nasdaq 100 Drops 1% on Hot CPI, SOXX Falls 7th Day: Stock Market Today

Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average

KRAS Inhibitor Market Projected to Reach $7.8 Billion by 2034

10 Health Care Stocks With Whale Alerts In Today’s Session

10 Health Care Stocks Whale Activity In Today’s Session

Amgen Hits Primary Endpoint In Sjögren's Trial, But Approval Filing Awaits Another Trial Data

AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR DAZODALIBEP IN MODERATE-TO-SEVERE SYSTEMIC SJÖGREN'S DISEASE

Bitcoin Tops $80,000, S&P 500 Slips as Yields Reclaim 5%: Stock Market Today

FDA APPROVES REDUCED MONITORING TIME FOR FIRST TWO DOSES OF IMDELLTRA®

Benzinga Bulls and Bears: GameStop, Marvell, Robinhood

10 Health Care Stocks With Whale Alerts In Today’s Session

AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

Pyxis Oncology Stock Soars Over 5% Overnight: Here's What You Need to Know

QUICK SPARK: Amgen Stock Eyes Worst Day Since October 2000

S&P 500, Nasdaq Slip as $98 Brent Reignites Inflation Fears: Stock Market Today

What's Going On With Amgen Stock Tuesday?

Astrazeneca Secures FDA Approval for New Breast Cancer Treatment

IMDELLTRA® IN COMBINATION WITH IMFINZI® DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER

Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

AMGEN TO PRESENT AT THE 2026 WELLS FARGO HEALTHCARE CONFERENCE

AMGEN'S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE

AstraZeneca, Amgen Score Phase 3 Win in Debilitating Swallowing Disease

TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS

10 Health Care Stocks Whale Activity In Today’s Session

9 Health Care Stocks Whale Activity In Today’s Session

Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'

Chubb, Toast And A Health Care Stock On CNBC’s ‘Final Trades’

Gold Jumps 4%, Dow Jones Smashes Record Highs: Stock Market Today

Amgen Q2 Adj. EPS $6.29 Beats $5.62 Estimate, Sales $10.054B Beat $9.421B Estimate

AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

SpaceX Could Swing $204 Billion After Earnings

Two Years to Build or Pay 200% — Which US Pharma Stocks Win?

AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

/C O R R E C T I O N -- Amgen/

The Dow Jones Earnings Showdown: 11 Blue‑Chips Step Up This Week

P/E Ratio Insights for Amgen

AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

Dogs Of The Dow: 10 High-Yield Stocks With Dividends Up To 6.8% - Including Several Warren Buffett Favorites

AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

Price Over Earnings Overview: Amgen

P/E Ratio Insights for Amgen